Denali Therapeutics Inc. · NASDAQ:DNLI
Thornberry Nancy sold 11,439 Denali Therapeutics Inc. shares (Form 4)
Traded Sep 2, 2026 · Filed Sep 4, 2026
On Sep 2, 2026, Thornberry Nancy (Director) sold 11,439 Denali Therapeutics Inc. shares at an average US$22.90 for US$262K under a trading plan, leaving 19,686 shares. Filed Sep 4, 2026 (Form 4).
- Sold
- 11,439 shares
- Price
- US$22.90 average (US$22.85 to US$23.74)
- Value
- US$262K
- Holding after
- 19,686 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Sale | 10,824 | US$22.85 | 20,301 | Direct |
| Sep 2, 2026 | Common Stock | Sale | 615 | US$23.74 | 19,686 | Direct |
Source
Related
- Denali Therapeutics Inc.
- Thornberry Nancy
- Denali Therapeutics Inc. shareholders
- Form 4 · Thornberry Nancy · Jun 5, 2026
- Form 4 · Chin Peter Scott · Sep 9, 2026
- Form 4 · Schuth Alexander O. · Sep 3, 2026
- Form 4 · Watts Ryan J. · Aug 14, 2026
- Form 4 · Schuth Alexander O. · Aug 13, 2026
- Schedule 13G/A · Baillie Gifford & Co · Aug 4, 2026